Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers
Molecular Therapy - Oncolytics · 2023-12 · 31 · 100735
DOI: 10.1016/j.omto.2023.100735 ↗Kurz gefasst
Korrektur in der Zeitschrift Molecular Therapy - Oncolytics, 2023-12. Verfasst von Thanyavi Chinsuwan und 10 weiteren Autor:innen. Die Arbeit wurde bisher 7-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Chinsuwan, T., Hirabayashi, K., Mishima, S., Hasegawa, A., Tanaka, M., Mochizuki, H., Shimoi, A., Murakami, T., Yagyu, S., Shimizu, K., & Nakazawa, Y. (2023). Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers. Molecular Therapy - Oncolytics, 31, 100735. https://doi.org/10.1016/j.omto.2023.100735
Vancouver
Chinsuwan T, Hirabayashi K, Mishima S, Hasegawa A, Tanaka M, Mochizuki H, et al. Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers. Molecular Therapy - Oncolytics. 2023;31:100735. doi:10.1016/j.omto.2023.100735
BibTeX
@article{Chinsuwan2023,
author = {Chinsuwan, Thanyavi and Hirabayashi, Koichi and Mishima, Shuji and Hasegawa, Aiko and Tanaka, Miyuki and Mochizuki, Hidemi and Shimoi, Akihito and Murakami, Takashi and Yagyu, Shigeki and Shimizu, Kimihiro and Nakazawa, Yozo},
title = {Ligand-based, piggyBac-engineered CAR-T cells targeting EGFR are safe and effective against non-small cell lung cancers},
journal = {Molecular Therapy - Oncolytics},
year = {2023},
volume = {31},
pages = {100735},
doi = {10.1016/j.omto.2023.100735}
}
EUVIMED